Role of inducible nitric oxide synthase expression in aberrant crypt foci-adenoma-carcinoma sequence

World Journal of Gastroenterology

Volumn 9, Issue 6, 2003, Pages 1246-1250

  Xu, Mei Hua ^a   Deng, Chang Sheng ^a   Zhu, You Qing ^a   Lin, Jun ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; NITRIC OXIDE SYNTHASE;

ADENOMA; ANGIOGENESIS; APOPTOSIS; ARTICLE; BIOLOGICAL MONITORING; CANCER DIAGNOSIS; CARCINOGENESIS; CARCINOMA; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPLASIA; FEMALE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE CRYPT; INTESTINE INJURY; LABELING INDEX; MALE; NICK END LABELING; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; TUMOR CELL LINE;

EID: 0037713736     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i6.1246     Document Type: Article

References (36)

1. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995; 93: 55-71
2. Holian O, Wahid S, Atten MJ, Attar BM. Inhibition of gastric cancer cell proliferation by resveratrol: Role of nitric oxide. Am J Physiol Gastrointest Liver Physiol 2002; 282: G809-816
3. Zhang K, Deng CS, Zhu YQ, Yang YP, Zhang YM. Significance of nuclear factor-κB, cyclooxygenase 2 and inducible nitric oxide synthase expression in human ulcerative colitis tissues. Shijie Huaren XiaoHua Zazhi 2002; 10: 575-578
4. Diao TJ, Yuan TY, Li YL. Immunologic role of nitric oxide in acute rejection of golden hamster to rat liver xenotransplantation. World J Gastroenterol 2002; 8: 746-751
5. Bing RJ, Miyataka M, Rich KA, Hanson N, Wang X, Slosser HD, Shi SR. Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer. Clin Cancer Res 2001; 7: 3385-3392
6. Song ZJ, Gong P, Wu YE. Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 2002; 8: 591-595
7. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998; 58: 334-341
8. Rao CV, Kawamori T, Hamid R, Reddy BS. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 1999; 20: 641-644
9. Nozoe T, Yasuda M, Honda M, Inutsuka S, Korenaga D. Immunohistochemical expression of cytokine induced nitric oxide synthase in colorectal carcinoma. Oncol Rep 2002; 9: 521-524
10. Nucci MR, Robinson CR, Longo P, Campbell P, Hamilton SR. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol 1997; 28: 1396-1407
11. Hao XP, Willis JE, Pretlow TG, Rao JS, MacLennan GT, Talbot IC, Pretlow TP. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer Res 2000; 60: 18-21
12. Li A, Yonezawa S, Matsukita S, Hasui K, Goto M, Tanaka S, Imai K, Sato E. Comparative study for histology, proliferative activity, glycoproteins, and p53 protein between old and recent colorectal adenomas in Japan. Cancer Lett 2001; 170: 45-52
13. Luo MJ, Lai MD. Identification of differentially expressed genes in normal mucosa, adenoma and adenocarcinoma of colon by SSH. World J Gastroenterol 2001; 7: 726-731
14. Bird RP, Good CK. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 2000; 112-113: 395-402
15. Yuan P, Sun MH, Zhang JS, Zhu XZ, Shi DR. APC and K-ras gene mutation in aberrant cryot foci of human colon. World J Gastroenterol 2001; 7: 352-356
16. Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 2000; 21: 1319-1327
17. Pedroni M, Sala E, Scarselli A, Borghi F, Menigatti M, Bennatti P, Percesepe A, Rossi G, Foroni M, Losi L, Di Gregorio C, De Pol A, Nascimbeni R, Di Betta E, Salerni B, De Leon MP, Roncucci L. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res 2001; 61: 896-899
18. Bouzuorene H, Chaubert P, Seelentag W, Bosman FT, Saraga E. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease. Hum Pathol 1999; 30: 66-71
19. Otori K, Sugiyama K, Hasebe T, Fukushima S, Esumi H. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res 1995; 55: 4743-4746
20. Shpitz B, Hay K, Medline A, Bruce WR, Bul SB, Gallinger S, Stern H. Natural history of aberrant crypt foci. A surgical approach. Dis Colon Rectum 1996; 39: 763-767
21. Wang LD, Zhou Q, Wei JP, Yang WC, Zhao X, Wang LX, Zou JX, Gao SS, Li YX, Yang CS. Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China. World J Gastroenterol 1998; 4: 287-293
22. Liu HF, Liu WW, Fang DC, Men RP. Expression and significance of proapoptotic gene Bax in gastric carcinoma. World J Gastroenterol 1999; 5: 15-17
23. Sun BH, Zhao XP, Wang BJ, Yang DL, Hao LJ. FADD and TRADD expression and apoptosis in primary human hepatocellular carcinoma. World J Gastroenterol 2000; 6: 223-227
24. Jia XD, Han C. Chemoprevention of tea on colorectal cancer induced by dimethylhydrazine in Wistar rats. World J Gastroenterol 2000; 6: 699-703
25. Zhang Z, Yuan Y, Gao H, Dong M, Wang L, Gong YH. Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J Gatroenterol 2001; 7: 779-782
26. Oda T, Takahashi A, Miyao N, Yanase M, Masumori N, Itoh N, Sato MA, Kon SI, Tsukamoto T. Cell proliferation, apoptosis, angiogenesis and growth rate of incidentally found renal cell carcinoma. Int J Urol 2003; 10: 13-18
27. Hao X, Du M, Bishop AE, Talbot IC. Imbalance between proliferation and apoptosis in the development of colorectal carcinoma. Virchows Arch 1998; 433: 523-527
28. Tanigawa N, Amaya H, Matsumura M, Lu C, Kitaoka A, Matsuyama K, Muraoka R. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 1997; 57: 1043-1046
29. Xiong B, Gong LL, Zhang F, Hu MB, Yuan HY. TGFβ1 expression and angiogenesis in colorectal cancer tissue. World J Gastroenterol 2002; 8: 496-498
30. Minagawa N, Nakayama Y, Hirata K, Onitsuka K, Inoue Y, Nagata N, Itoh H. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer. Anticancer Res 2002; 22: 2957-2963
31. Fan YF, Huang ZH. Angiogenesis inhibitor TNF-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo. World J Gastroenterol 2002; 8: 853-856
32. Tao HQ, Lin YZ, Wang RN. Significance of vascular endothelial growth factor messenger RNA expression in gastric cancer World J Gastroenterol 1998; 4: 10-13
33. Thomsen LL, Miles DW. Role of nitric oxide in tumour progression: Lessons from human tumours. Cancer Metastsis Rev 1998; 17: 107-118
34. Sinicrope FA, Roddey G, McDonnell TJ, Shen Y, Cleary KR, Stephens LC. Increased apoptosis accompanies neoplastic develoment in the human colorectum. Clin Cancer Res 1996; 2: 1999-2006
35. Wang Q, Wu JS, Gao DM, Lai DL, Ma QJ. Significance of EGF recpetor and TGF-aα messenger RNA exression in colorectal carcinoma. Shijie Huaren Xiaohua Zazhi 1999; 7: 590-592
36. Xia L, Yuan YZ, Xu CD, Zhang YP, Qiao MM, Xu JX. Effects of epidermal growth factor on the growth of human gastric cancer cell and the implanted tumor of nude mice. World J Gastroenterol 2002; 8: 455-458